Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin

BACKGROUND: Fecal biomarkers have emerged as one of the most useful tools for clinical management of inflammatory bowel disease (IBD). Oncostatin M (OSM), like fecal calprotectin (FC), is highly expressed in the inflamed intestinal mucosa which may have potential usefulness. We aimed to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Ying, Dai, Yibei, Zhang, Lingyu, Wang, Danhua, Hu, Wen, Yu, Qiao, Wang, Xuchu, Yu, Pan, Liu, Weiwei, Ping, Ying, Sun, Tao, Sang, Yiwen, Liu, Zhenping, Chen, Yan, Tao, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647726/
https://www.ncbi.nlm.nih.gov/pubmed/34880643
http://dx.doi.org/10.2147/JIR.S342846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647726/
https://www.ncbi.nlm.nih.gov/pubmed/34880643
http://dx.doi.org/10.2147/JIR.S342846

Ejemplares similares